Mutations within Four Distinct Gag Proteins Are Required To Restore Replication of Human Immunodeficiency Virus Type 1 after Deletion Mutagenesis within the Dimerization Initiation Site

ABSTRACT Human immunodeficiency virus type 1 (HIV-1) genomic RNA segments at nucleotide (nt) positions +240 to +274 are thought to form a stem-loop secondary structure, termed SL1, that serves as a dimerization initiation site for viral genomic RNA. We have generated two distinct deletion mutations within this region, termed BH10-LD3 and BH10-LD4, involving nt positions +238 to +253 and +261 to +274, respectively, and have shown that each of these resulted in significant diminutions in levels of viral infectiousness. However, long-term culture of each of these viruses in MT-2 cells resulted in a restoration of infectiousness, due to a series of compensatory point mutations within four distinct proteins that are normally cleaved from the Gag precursor. In the case of BH10-LD3, these four mutations were MA1, CA1, MP2, and MNC, and they involved changes of amino acid Val-35 to Ile within the matrix protein (MA), Ile-91 to Thr within the capsid (CA), Thr-12 to Ile within p2, and Thr-24 to Ile within the nucleocapsid (NC). The order in which these mutations were acquired by the mutated BH10-LD3 was MNC > CA1 > MP2 > MA1. The results of site-directed mutagenesis studies confirmed that each of these four substitutions contributed to the increased viability of the mutated BH10-LD3 viruses and that the MNC substitution, which was acquired first, played the most important role in this regard. Three point mutations, MP2, MNC, and MA2, were also shown to be sequentially acquired by viruses that had emerged in culture from the BH10-LD4 deletion. The first two of these were identical to those described above, while the last involved a change of Val-35 to Leu. All three of these substitutions were necessary to restore the infectiousness of mutated BH10-LD4 viruses to wild-type levels, although the MP2 mutation alone, but neither of the other two substitutions, was able to confer some viability on BH10-LD4 viruses. Studies of viral RNA packaging showed that the BH10-LD4 deletion only marginally impaired encapsidation while the BH10-LD3 deletion caused a severe deficit in this regard.

[1]  W. Sundquist,et al.  Crystal structures of the trimeric human immunodeficiency virus type 1 matrix protein: implications for membrane association and assembly. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[2]  T. Rivers THE NATURE OF VIRUSES , 1932 .

[3]  A. Gronenborn,et al.  Identification of a binding site for the human immunodeficiency virus type 1 nucleocapsid protein. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[4]  H. Zentgraf,et al.  The spacer peptide between human immunodeficiency virus capsid and nucleocapsid proteins is essential for ordered assembly and viral infectivity , 1995, Journal of virology.

[5]  B. Berkhout,et al.  Role of the DIS hairpin in replication of human immunodeficiency virus type 1 , 1996, Journal of virology.

[6]  A. Kaplan,et al.  The p2 domain of human immunodeficiency virus type 1 Gag regulates sequential proteolytic processing and is required to produce fully infectious virions , 1994, Journal of virology.

[7]  C. Ehresmann,et al.  Functional sites in the 5' region of human immunodeficiency virus type 1 RNA form defined structural domains. , 1993, Journal of molecular biology.

[8]  S. Goff,et al.  Analysis of binding elements in the human immunodeficiency virus type 1 genomic RNA and nucleocapsid protein. , 1994, Virology.

[9]  R. Young,et al.  Mutations of RNA and protein sequences involved in human immunodeficiency virus type 1 packaging result in production of noninfectious virus , 1990, Journal of virology.

[10]  M. Wainberg,et al.  Mutations in the kissing-loop hairpin of human immunodeficiency virus type 1 reduce viral infectivity as well as genomic RNA packaging and dimerization , 1997, Journal of virology.

[11]  J. Luban,et al.  Specific binding of human immunodeficiency virus type 1 gag polyprotein and nucleocapsid protein to viral RNAs detected by RNA mobility shift assays , 1993, Journal of virology.

[12]  A. Panganiban,et al.  Position dependence of functional hairpins important for human immunodeficiency virus type 1 RNA encapsidation in vivo , 1997, Journal of virology.

[13]  C. Ehresmann,et al.  A dual role of the putative RNA dimerization initiation site of human immunodeficiency virus type 1 in genomic RNA packaging and proviral DNA synthesis , 1996, Journal of virology.

[14]  S. Goff,et al.  RNA packaging. , 1996, Current topics in microbiology and immunology.

[15]  M Laughrea,et al.  A 19-nucleotide sequence upstream of the 5' major splice donor is part of the dimerization domain of human immunodeficiency virus 1 genomic RNA. , 1994, Biochemistry.

[16]  S. Höglund,et al.  A Putative α-Helical Structure Which Overlaps the Capsid-p2 Boundary in the Human Immunodeficiency Virus Type 1 Gag Precursor Is Crucial for Viral Particle Assembly , 1998, Journal of Virology.

[17]  W. Sundquist,et al.  Crystal Structure of Human Cyclophilin A Bound to the Amino-Terminal Domain of HIV-1 Capsid , 1996, Cell.

[18]  J. Luban,et al.  Mutational analysis of cis-acting packaging signals in human immunodeficiency virus type 1 RNA , 1994, Journal of virology.

[19]  T. Parslow,et al.  Mutant human immunodeficiency virus type 1 genomes with defects in RNA dimerization or encapsidation , 1997, Journal of virology.

[20]  H. Kräusslich,et al.  Sequential Steps in Human Immunodeficiency Virus Particle Maturation Revealed by Alterations of Individual Gag Polyprotein Cleavage Sites , 1998, Journal of Virology.

[21]  A. Aldovini,et al.  Charged amino acid residues of human immunodeficiency virus type 1 nucleocapsid p7 protein involved in RNA packaging and infectivity , 1996, Journal of virology.

[22]  M. Wainberg,et al.  Sequence elements downstream of the human immunodeficiency virus type 1 long terminal repeat are required for efficient viral gene transcription. , 1997, Journal of molecular biology.

[23]  D. Sen,et al.  Mode of dimerization of HIV-1 genomic RNA. , 1993, Biochemistry.

[24]  S. Goff,et al.  Retroviral nucleocapsid domains mediate the specific recognition of genomic viral RNAs by chimeric Gag polyproteins during RNA packaging in vivo , 1995, Journal of virology.

[25]  L. Arthur,et al.  The two zinc fingers in the human immunodeficiency virus type 1 nucleocapsid protein are not functionally equivalent , 1993, Journal of virology.

[26]  T. Parslow,et al.  Requirements for kissing-loop-mediated dimerization of human immunodeficiency virus RNA , 1996, Journal of virology.

[27]  A. Scheid,et al.  Exon 1 leader sequences downstream of U5 are important for efficient human immunodeficiency virus type 1 gene expression , 1997, Journal of virology.

[28]  W. Sundquist,et al.  Molecular recognition in the HIV-1 capsid/cyclophilin A complex. , 1997, Journal of molecular biology.

[29]  A. E. Boycott Nature of Viruses. , 1931, Nature.

[30]  C. Sassetti,et al.  RNA secondary structure and binding sites for gag gene products in the 5' packaging signal of human immunodeficiency virus type 1 , 1995, Journal of virology.

[31]  H. Kim,et al.  A short sequence upstream of the 5' major splice site is important for encapsidation of HIV-1 genomic RNA. , 1994, Virology.

[32]  C. Ehresmann,et al.  Mutational analysis of the bipartite dimer linkage structure of human immunodeficiency virus type 1 genomic RNA. , 1994, The Journal of biological chemistry.

[33]  B. Roques,et al.  First glimpses at structure-function relationships of the nucleocapsid protein of retroviruses. , 1995, Journal of molecular biology.

[34]  P. Borer,et al.  Structure of the HIV-1 nucleocapsid protein bound to the SL3 psi-RNA recognition element. , 1998, Science.

[35]  A. Panganiban,et al.  The human immunodeficiency virus type 1 encapsidation site is a multipartite RNA element composed of functional hairpin structures , 1996, Journal of virology.

[36]  J. Kaye,et al.  Nonreciprocal Packaging of Human Immunodeficiency Virus Type 1 and Type 2 RNA: a Possible Role for the p2 Domain of Gag in RNA Encapsidation , 1998, Journal of Virology.

[37]  A. Lever,et al.  The human immunodeficiency virus type 1 packaging signal and major splice donor region have a conserved stable secondary structure , 1992, Journal of virology.

[38]  J. Sodroski,et al.  Identification of a sequence required for efficient packaging of human immunodeficiency virus type 1 RNA into virions , 1989, Journal of virology.

[39]  C. Ehresmann,et al.  Dimerization of human immunodeficiency virus type 1 RNA involves sequences located upstream of the splice donor site. , 1994, Nucleic acids research.

[40]  A. Panganiban,et al.  Human immunodeficiency virus type 1 RNA outside the primary encapsidation and dimer linkage region affects RNA dimer stability in vivo , 1997, Journal of virology.

[41]  M. Wainberg,et al.  Compensatory Point Mutations in the Human Immunodeficiency Virus Type 1 Gag Region That Are Distal from Deletion Mutations in the Dimerization Initiation Site Can Restore Viral Replication , 1998, Journal of Virology.

[42]  K. Moelling,et al.  Specific binding of HIV‐1 nucleocapsid protein to PSI RNA in vitro requires N‐terminal zinc finger and flanking basic amino acid residues. , 1994, The EMBO journal.

[43]  C. Ehresmann,et al.  Identification of the primary site of the human immunodeficiency virus type 1 RNA dimerization in vitro. , 1994, Proceedings of the National Academy of Sciences of the United States of America.